Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening
David A. Lieberman(Oregon Health & Science University), Rosita van den Puttelaar(Erasmus MC), Folasade P. May(University of California, Los Angeles), John M. Inadomi(University of Utah), Timothy R. Church(University of Minnesota), John M. Carethers(University of San Diego), Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Richard C. Wender(American Cancer Society), Uri Ladabaum(Stanford University), Anjelica Q. Davis, Aasma Shaukat(University of Minnesota), Pedro Nascimento de Lima(RAND Corporation), Chyke A. Doubeni(The Ohio State University Wexner Medical Center)
Cited by 17
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States
|Clinical Infectious Diseases|2020|1.5k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
|Gastroenterology|2011|1.1k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k